- Home
- NAMS vs HSAI Comparison
NAMS vs HSAI Comparison
Compare NAMS & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- HSAI
- Stock Information
- Founded
- NAMS 2019
- HSAI 2014
- Country
- NAMS Netherlands
- HSAI China
- Employees
- NAMS N/A
- HSAI N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- HSAI
- Sector
- NAMS Health Care
- HSAI
- Exchange
- NAMS Nasdaq
- HSAI Nasdaq
- Market Cap
- NAMS 1.7B
- HSAI 1.4B
- IPO Year
- NAMS N/A
- HSAI 2023
- Fundamental
- Price
- NAMS $25.50
- HSAI $12.28
- Analyst Decision
- NAMS Strong Buy
- HSAI
- Analyst Count
- NAMS 6
- HSAI 0
- Target Price
- NAMS $36.20
- HSAI N/A
- AVG Volume (30 Days)
- NAMS 1.4M
- HSAI 5.6M
- Earning Date
- NAMS 02-06-2025
- HSAI 11-25-2024
- Dividend Yield
- NAMS N/A
- HSAI N/A
- EPS Growth
- NAMS N/A
- HSAI N/A
- EPS
- NAMS N/A
- HSAI N/A
- Revenue
- NAMS $33,594,000.00
- HSAI $273,516,715.00
- Revenue This Year
- NAMS $129.49
- HSAI $16.73
- Revenue Next Year
- NAMS N/A
- HSAI $57.96
- P/E Ratio
- NAMS N/A
- HSAI N/A
- Revenue Growth
- NAMS 78.77
- HSAI 11.22
- 52 Week Low
- NAMS $10.50
- HSAI $3.28
- 52 Week High
- NAMS $27.29
- HSAI $14.40
- Technical
- Relative Strength Index (RSI)
- NAMS 62.30
- HSAI 64.87
- Support Level
- NAMS $24.40
- HSAI $10.17
- Resistance Level
- NAMS $26.95
- HSAI $14.40
- Average True Range (ATR)
- NAMS 1.66
- HSAI 1.47
- MACD
- NAMS 0.41
- HSAI 0.08
- Stochastic Oscillator
- NAMS 81.51
- HSAI 69.45
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About HSAI Hesai Group each ADS represents one Class B ordinary share
Hesai Group is engaged in the development, manufacture, and sales of three dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. The Group organized its operations into two segments: the LiDAR segment and the gas detection segment, out of which LiDAR segments derives maximum revenue. Geographically, the company operates into North America, Mainland China, Europe and Other regions.